OneOme and Mayo Clinic develop a personalized prescription drug test that can predict patient's responses toward medications. The comprehensive examination is called RightMed and it is a physician-ordered genetic test that provides an accurate analysis and points at which drugs are likely to be a good fit. This cost-effective personalized prescription approach does not only provide accuracy in treatment, but it also protects the patient from adverse drug side-effects.
The RightMed test is geared toward abnormalities like depression, anxiety, ADHD and other mental health conditions. Statistics point that an average of 50% of patients do not respond well to their medications, therefore, the RightMed personalized prescription test will definitely boost efficiency, accuracy and comfortability during treatment, ultimately helping patients get better faster.
Why This Trend Is Growing
- Personalized Prescription Tests
- Opportunity for developing advanced genetic testing to tailor medication based on individual DNA.
- Accurate Medication Analysis
- Potential for creating comprehensive examination tools to determine the best-fit drugs for patients.
- Improving Treatment Efficiency
- Opportunity to enhance patient outcomes by optimizing medication choices and reducing adverse drug side-effects.
Industries Being Reshaped
- Genetic Testing
- Disruptive innovation potential in advancing personalized prescription tests using genomic technologies.
- Healthcare
- Opportunity in improving patient care through accurate medication analysis and personalized treatment options.
- Pharmaceutical
- Potential for developing drugs that are tailored to specific genetic profiles, maximizing treatment efficacy and safety.
